炎症性肠病与小肠癌风险:丹麦和瑞典的双国家人群队列研究
该双国家人群队列研究纳入1969-2017年丹麦和瑞典的161 896例炎症性肠病(IBD)患者及匹配参照个体,评估小细胞癌(SBC)发病与死亡风险。结果显示克罗恩病(CD)患者SBC发病风险显著升高(aHR 9.09,95%CI 7.34-11.3),溃疡性结肠炎(UC)患者亦升高(aHR 1.85,95%CI 1.43-2.39);SBC相关死亡风险在CD(aHR 6.59)和UC(aHR 1.57)中均增加,但绝对风险较低。
要点
- CD患者SBC发病aHR为9.09(95%CI 7.34-11.3),UC患者为1.85(95%CI 1.43-2.39),均高于参照个体。
- CD患者SBC相关死亡aHR为6.59(95%CI 4.74-9.15),UC患者为1.57(95%CI 1.07-2.32)。
- CD患者10年随访中每385例增加1例SBC,UC患者每500例增加1例,绝对风险较低。
核心结论
- IBD患者中小肠癌及小肠癌死亡更常见,尤其是CD患者,但绝对风险较低。
研究设计与样本
- 丹麦和瑞典的双国家、人群基础队列研究,纳入1969-2017年IBD患者161 896例(CD 47 370例,UC 97 515例,未分类IBD 17 011例)及匹配的普通人群参照个体。
- 采用Cox回归估计调整风险比(aHR)。
主要发现
- 随访期间IBD患者诊断SBC 237例(CD 24.4/10万人年,UC 5.88/10万人年),参照个体640例(CD参照2.81/10万人年,UC参照3.32/10万人年)。
- CD患者10年随访每385例增加1例SBC,UC患者每500例增加1例。
- SBC发病aHR在CD为9.09(95%CI 7.34-11.3),UC为1.85(95%CI 1.43-2.39)。
- 排除IBD诊断后第一年,SBC发病aHR在CD降至4.96,UC降至1.69。
- CD患者中,新近诊断、儿童期发病、回肠型和狭窄型CD的HR独立最高;SBC相关死亡aHR在CD为6.59(95%CI 4.74-9.15),UC为1.57(95%CI 1.07-2.32)。
关键数值与推荐
- SBC发病aHR:CD 9.09(95%CI 7.34-11.3),UC 1.85(95%CI 1.43-2.39),参照组为普通人群。
- 排除第一年后的SBC发病aHR:CD 4.96,UC 1.69。
- SBC相关死亡aHR:CD 6.59(95%CI 4.74-9.15),UC 1.57(95%CI 1.07-2.32)。
- 绝对风险:CD患者10年每385例增加1例SBC,UC患者每500例增加1例。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Crohn's disease (CD) is associated with increased risk of small bowel cancer (SBC), but previous studies have been small. We aimed to examine the risk of incident SBC and death from SBC in patients with inflammatory bowel disease (IBD). DESIGN: In a binational, population-based cohort study from Sweden and Denmark of patients with IBD during 1969-2017 and matched reference individuals from the general population, we evaluated the risk of incident SBC and death from SBC. Cox regression was used to estimate adjusted hazard ratios (aHRs). RESULTS: We identified 161 896 individuals with IBD (CD: 47 370; UC: 97 515; unclassified IBD: 17 011). During follow-up, 237 cases of SBC were diagnosed in patients with IBD (CD: 24.4/100 000 person-years; UC: 5.88/100 000 person-years), compared with 640 cases in reference individuals (2.81/100 000 person-years and 3.32/100 000 person-years, respectively). This corresponded to one extra case of SBC in 385 patients with CD and one extra case in 500 patients with UC, followed up for 10 years. The aHR for incident SBC was 9.09 (95% CI 7.34 to 11.3) in CD and 1.85 (95% CI 1.43 to 2.39) in UC. Excluding the first year after an IBD diagnosis, the aHRs for incident SBC decreased to 4.96 in CD and 1.69 in UC. Among patients with CD, HRs were independently highest for recently diagnosed, childhood-onset, ileal and stricturing CD. The relative hazard of SBC-related death was increased in both patients with CD (aHR 6.59, 95% CI 4.74 to 9.15) and patients with UC (aHR 1.57; 95% CI 1.07 to 2.32). CONCLUSION: SBC and death from SBC were more common in patients with IBD, particularly among patients with CD, although absolute risks were low.
引用
- Axelrad JE, Olén O, Sachs MC, et al. Inflammatory bowel disease and risk of small bowel cancer: a binational population-based cohort study from Denmark and Sweden. Gut. 2020. PMID: 32474410. doi:10.1136/gutjnl-2020-320945
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。